Advertisement
Screener

Coeptis Therapeutics, Inc. Long-Term Debt, Maturity, Year Two

Coeptis Therapeutics, Inc. Long-Term Debt, Maturity, Year Two

Coeptis Therapeutics, Inc. had Long-Term Debt, Maturity, Year Two of $0 as of 2022-06-30, per its 10-Q filed 2022-08-02.

Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2022-11-08

  • 2022-06-30: Long-Term Debt, Maturity, Year Two $0.00.
  • 2022-03-31: Long-Term Debt, Maturity, Year Two $1.50M.
  • 2021-12-31: Long-Term Debt, Maturity, Year Two $0.00; Long-Term Debt, Maturity, Year Two as first filed $1.50M.
  • 2021-09-30: Long-Term Debt, Maturity, Year Two $1.50M.
Period endLong-Term Debt, Maturity, Year TwoLong-Term Debt, Maturity, Year Two as first filed
2022-06-30$0.00
10-Q · filed 2022-08-02
2022-03-31$1.50M
10-Q · filed 2022-05-12
2021-12-31$0.00
10-Q · filed 2022-11-08
$1.50M
10-K · filed 2022-03-11
2021-09-30$1.50M
10-Q · filed 2021-11-15
2021-06-30$2.00K
10-Q · filed 2021-08-16
2021-03-31$2.00K
10-Q/A · filed 2021-05-18